Why the study?
Does heparin improve survival in patients with cancer?
Does heparin improve survival in patients with cancer?
Heparin, particularly low molecular weight heparin, may possess antineoplastic activity that improves survival in cancer patients independent of its anticoagulant effects, warranting further clinical investigation.
No takes yet. Share an insight, caveat, or question.
LMWH may improve cancer survival beyond anticoagulation; leaves open need for RCTs before any practice change.
Ornstein et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: